发明名称 PHARMACEUTICAL COMPOSITIONS CONSISTING OR CONSISTING ESSENTIALLY OF LIPOSOMES AND PROCESSES FOR MAKING SAME
摘要 <p>A method is disclosed for purifying non-homogeneous systems, known as liposomic suspensions, from non-entrapped drugs wherein said suspensions are treated with liquid or solid polymers of synthetic and organic nature having chemical functionality, which are used as ion-exchangers. The liquid or solid polymers are based on styrene, divinylbenzene, acrylic acid, methacrylic acid, and the like, normally known as ion-exchange resins, and may include carboxylic, phosphonic, or sulphonic functions of different matrices. The ion-exchange resins may also include salified quaternary ammonium, primary, secondary and tertiary amminic or phosphinic functions or other functions with different matrices, including phenolformaldehyde, styrene-divinyl-benzene, acrylates, methacrylates, hydrocarbons and condensation-resins. Treatment may also be carried out with polymers, copolymers, or mixtures thereof, not having any specific chemical function and which normally, but not exclusively, react according to Van der Waals' forces, commonly known as adsorbents. The invention also includes pharmaceutical compositions consisting or consisting essentially of lyophilic liposomes of doxorubicin hydrochloride, aminosidine sulphate or 5-fluoro-uracil.</p>
申请公布号 CA1148470(A) 申请公布日期 1983.06.21
申请号 CA19800343663 申请日期 1980.01.15
申请人 FARMITALIA CARLO ERBA S.P.A. 发明人 MORO, LUIGI;NERI, GUIDO;RIGAMONTI, ALESSANDRO
分类号 A61K9/50;A61K9/127;A61K31/505;A61K31/70;A61K47/00;(IPC1-7):A61K37/22 主分类号 A61K9/50
代理机构 代理人
主权项
地址